NYU Langone Health
New York, 10016, United States
NCT Number: NCT04971278
NYU's High Risk Program targets patients who may be more likely to have increased hospitalization due to health conditions that may cause death in the near future. Community Health Workers, a home visiting doctor service, a supportive care nurse, and behavioral health specialist engage the population to address a range of biopsychosocial needs with end goal in increasing support in the community and engaging palliative and hospice care when appropriate to prevent hospital readmissions, shorten length of stay, reduce hospital utilization, and decrease overall patient cost with a focus on hospital spend.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
New York, 10016, United States
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Community Health Workers, a home visiting doctor service, a supportive care nurse, and behavioral health specialist engage the population to address a range of biopsychosocial needs with end goal in increasing support in the community and engaging palliative and hospice care when appropriate to prevent hospital readmissions, shorten length of stay, reduce hospital utilization, and decrease overall patient cost with a focus on hospital spend.
Time frame: 2 years
How many and how often are ACP notes written for patients
NYU Langone Health
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05780164
Behavior, Communication
Oxford, Oxfordshire, United Kingdom
View Trial DetailsNCT05353049
Behavior, Behavioral Symptoms
Salamanca, Castille and León, Spain
View Trial DetailsNCT04055311
Behavior, Bladder Cancer
Manhasset, New York, United States
View Trial DetailsNCT04993807
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial Details